Team:UCL London/Bibliography

From 2011.igem.org

(Difference between revisions)
Line 8: Line 8:
<ol>
<ol>
<li><a name="manufacturing-1" href="http://www.ncbi.nlm.nih.gov/pubmed/19075838" target="_blank">http://www.ncbi.nlm.nih.gov/pubmed/19075838</a></li>
<li><a name="manufacturing-1" href="http://www.ncbi.nlm.nih.gov/pubmed/19075838" target="_blank">http://www.ncbi.nlm.nih.gov/pubmed/19075838</a></li>
 +
</ol>
 +
<h2>Medicine</h2>
 +
<ol>
 +
<li><a name="medicine-1"></a>http://www.tsim.org.tw/article/A95/abstract/10-afternoon/Rm102/H5N1-3.pdf</li>
 +
<li><a name="medicine-2"></a>WHO, Avian Influenza, [Online] Available at:<http://www.who.int/mediacentre/factsheets/avian_influenza/en/#history> [Accessed on 16 September 2011)</li>
 +
<li><a name="medicine-3"></a>TED, Seth Berkley: HIV and flu -- the vaccine strategy, [Online] Available at:
 +
<http://www.ted.com/talks/lang/eng/seth_berkley_hiv_and_flu_the_vaccine_strategy.html> [Accessed on 14 September 2011)
 +
</li>
 +
<li><a name="medicine-4"></a>http://www.medscape.com/viewarticle/487616</li>
 +
<li><a name="medicine-5"></a>Recombinant/ purified protein vaccines, [Online] Available at:<http://www.bvgh.org/Biopharmaceutical-Solutions/Global-Health-Primer/Targets/cid/ViewDetails/ItemID/10.aspx> [Accessed on 17 September 2011)</li>
 +
<li><a name="medicine-6"></a>Discover Magazine: Vaccine Production Is Horribly Outdated. Here Are 3 Ways to Fix It. [Online] Available at: <http://discovermagazine.com/2009/jul-aug/27-vaccine-production-horribly-outdated-3-ways-fix-it/article_view?b_start:int=0&-C> [Accessed on 17 September 2011)</li>
 +
<li><a name="medicine-7"></a>www.pitt.edu/~super7/32011-33001/32731.ppt</li>
 +
<li><a name="medicine-8"></a>NAE Website - Cell-Culture-Based Vaccine Production: Technological Options, [Online] Available at: <http://www.nae.edu/Publications/Bridge/EngineeringandVaccineProductionforanInfluenzaPandemic/Cell-Culture-BasedVaccineProductionTechnologicalOptions.aspx> [Accessed on 16 September 2011)</li>
 +
<li><a name="medicine-9"></a>David B. Weiner and Ronald C. Kennedy, 1999. Genetic Vaccines. Scientific American, July Issue, pp. 50-57.
 +
 +
Cui, Z., 2005. DNA vaccine. Advances in Genetics, Volume 54, pp. 257-289.
 +
 +
DNA vaccination: Immune response raised by DNA vaccines [online] Available at: <http://en.wikipedia.org/wiki/DNA_vaccination#Immune_response_raised_by_DNA_vaccines> [Accessed on 7 September 2011]
 +
 +
David B. Weiner and Ronald C. Kennedy, 1999. How DNA Vaccines Work. [diagram] Same journal.
 +
</li>
 +
<li><a name="medicine-10"></a>Wikipedia, Gene gun, [online] Available at: <http://en.wikipedia.org/wiki/Gene_gun> [Accessed on 8 September 2011)</li>
 +
<li><a name="medicine-11"></a>Inovio, Technology: Electroporation-Based DNA Delivery, [online] Available at: <http://www.inovio.com/technology/electroporation-baseddnadelivery.htm> [Accessed on 8 September 2011)</li>
 +
<li><a name="medicine-12"></a>Pilling et al., 2002. The Assessment of Local Tolerance, Acute Toxicity, and DNA Biodistribution Following Particle-Mediated Delivery of a DNA Vaccine to Minipigs. Toxicologic Pathology, 30(3), pp 298-305.</li>
 +
<li><a name="medicine-13"></a>Sheets et al., 2006. Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene Inserts. Toxicological Sciences, 91(2), pp 610-619.</li>
 +
<li><a name="medicine-14"></a>Sheets et al., 2006. Toxicological Safety Evaluation of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar Despite Differing Plasmid Backbones or Gene-Inserts. Toxicological Sciences, 91(2), pp 620-630</li>
 +
<li><a name="medicine-15"></a>http://www.academicjournals.org/AJB/PDF/pdf2011/7Sep/Roy%20et%20al.pdf</li>
 +
<li><a name="medicine-16"></a>NAE Website - Cell-Culture-Based Vaccine Production: Technological Options, [Online] Available at: <http://www.nae.edu/Publications/Bridge/EngineeringandVaccineProductionforanInfluenzaPandemic/Cell-Culture-BasedVaccineProductionTechnologicalOptions.aspx> [Accessed on 7 September 2011)</li>
 +
<li><a name="medicine-17"></a>Strategies for production of viral vaccines, [Online] Available at: <http://virology-online.com/questions/89-2.htm> [Accessed on 14 September 2011)</li>
 +
<li><a name="medicine-18"></a>Strategies for production of viral vaccines, [Online] Available at: <http://virology-online.com/questions/89-2.htm> [Accessed on 14 September 2011)</li>
 +
<li><a name="medicine-19"></a>Strategies for production of viral vaccines, [Online] Available at: <http://virology-online.com/questions/89-2.htm> [Accessed on 14 September 2011)</li>
 +
<li><a name="medicine-20"></a>U.S. Department of Health and Human Services, CBER and FDA Guidance document. Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications (11/07)</li>
 +
<li><a name="medicine-21"></a>Urthaler et al., 2005. Improvement of transfection efficiency by using supercoiled plasmid DNA purified with arginine affinity chromatography. J Gene Med, 11(1): 79-88.</li>
 +
<li><a name="medicine-22"></a>Cupillard et al., 2005. Impact of plasmid supercoiling on the efficacy of a rabies DNA vaccine to protect cats. Vaccine, 23: 1910-1916.</li>
 +
<li><a name="medicine-23"></a>Jensen et al., 1999. Extensive regulation compromises the extent to which DNA gyrase controls supercoiling and growth rate of Escherichia coli. Eur. I. Biochem., 266: 865-877.</li>
 +
<li><a name="medicine-24"></a>Trigueros S and Roca J, 2002. Failure to relax negative supercoiling of DNA is a primary cause of mitotic hyper-recombination in topoisomerase-deficient yeast cells. J Biol Chem., 277(40):37207-11.</li>
</ol>
</ol>
<h2>Safety</h2>
<h2>Safety</h2>

Revision as of 23:28, 21 September 2011

Bibliography

Research

  1. Paper I (Ellen et al., 2011)

Manufacturing

  1. http://www.ncbi.nlm.nih.gov/pubmed/19075838

Medicine

  1. http://www.tsim.org.tw/article/A95/abstract/10-afternoon/Rm102/H5N1-3.pdf
  2. WHO, Avian Influenza, [Online] Available at: [Accessed on 16 September 2011)
  3. TED, Seth Berkley: HIV and flu -- the vaccine strategy, [Online] Available at: [Accessed on 14 September 2011)
  4. http://www.medscape.com/viewarticle/487616
  5. Recombinant/ purified protein vaccines, [Online] Available at: [Accessed on 17 September 2011)
  6. Discover Magazine: Vaccine Production Is Horribly Outdated. Here Are 3 Ways to Fix It. [Online] Available at: [Accessed on 17 September 2011)
  7. www.pitt.edu/~super7/32011-33001/32731.ppt
  8. NAE Website - Cell-Culture-Based Vaccine Production: Technological Options, [Online] Available at: [Accessed on 16 September 2011)
  9. David B. Weiner and Ronald C. Kennedy, 1999. Genetic Vaccines. Scientific American, July Issue, pp. 50-57. Cui, Z., 2005. DNA vaccine. Advances in Genetics, Volume 54, pp. 257-289. DNA vaccination: Immune response raised by DNA vaccines [online] Available at: [Accessed on 7 September 2011] David B. Weiner and Ronald C. Kennedy, 1999. How DNA Vaccines Work. [diagram] Same journal.
  10. Wikipedia, Gene gun, [online] Available at: [Accessed on 8 September 2011)
  11. Inovio, Technology: Electroporation-Based DNA Delivery, [online] Available at: [Accessed on 8 September 2011)
  12. Pilling et al., 2002. The Assessment of Local Tolerance, Acute Toxicity, and DNA Biodistribution Following Particle-Mediated Delivery of a DNA Vaccine to Minipigs. Toxicologic Pathology, 30(3), pp 298-305.
  13. Sheets et al., 2006. Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene Inserts. Toxicological Sciences, 91(2), pp 610-619.
  14. Sheets et al., 2006. Toxicological Safety Evaluation of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar Despite Differing Plasmid Backbones or Gene-Inserts. Toxicological Sciences, 91(2), pp 620-630
  15. http://www.academicjournals.org/AJB/PDF/pdf2011/7Sep/Roy%20et%20al.pdf
  16. NAE Website - Cell-Culture-Based Vaccine Production: Technological Options, [Online] Available at: [Accessed on 7 September 2011)
  17. Strategies for production of viral vaccines, [Online] Available at: [Accessed on 14 September 2011)
  18. Strategies for production of viral vaccines, [Online] Available at: [Accessed on 14 September 2011)
  19. Strategies for production of viral vaccines, [Online] Available at: [Accessed on 14 September 2011)
  20. U.S. Department of Health and Human Services, CBER and FDA Guidance document. Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications (11/07)
  21. Urthaler et al., 2005. Improvement of transfection efficiency by using supercoiled plasmid DNA purified with arginine affinity chromatography. J Gene Med, 11(1): 79-88.
  22. Cupillard et al., 2005. Impact of plasmid supercoiling on the efficacy of a rabies DNA vaccine to protect cats. Vaccine, 23: 1910-1916.
  23. Jensen et al., 1999. Extensive regulation compromises the extent to which DNA gyrase controls supercoiling and growth rate of Escherichia coli. Eur. I. Biochem., 266: 865-877.
  24. Trigueros S and Roca J, 2002. Failure to relax negative supercoiling of DNA is a primary cause of mitotic hyper-recombination in topoisomerase-deficient yeast cells. J Biol Chem., 277(40):37207-11.

Safety

  1. Cupillard, L. et al., 2005. Impact of plasmid supercoiling on the efficacy of a rabies DNA vaccines to protect cats. Vaccine 23: 1910-1916.
  2. Reece, R.J. and Maxwell, A., 1991. DNA Gyrase: Structure and Function. Critical Reviews in Biochemistry and Molecular Biology. 26 (3/4):335-375.
  3. Safety Handbook, 2010/2011. Department of Biochemical Engineering,UCL.
  4. Institute of Child Health Flow Cytometry Core Facility, UCL Biosafety: Important health and safety documents, [online]
    Available from: http://www.ucl.ac.uk/ich/services/lab-services/FCCF/biosafety (Accessed on 25 August 2011)

Retrieved from "http://2011.igem.org/Team:UCL_London/Bibliography"